Skip to main content
SpringerLink
Log in

Pharmacokinetic Investigations in Elderly Patients Clinical and Ethical Considerations

  • Leading Article
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Abernethy DR, Schwartz JB, Todd EL, Snow E. Verapamil pharmacodynamics and disposition in young and elderly hypertensive patients. Annals of Internal Medicine 105: 329–336, 1986

    PubMed  CAS  Google Scholar 

  • Avorn J. Biomedical and social determinants of cognitive impairment in the elderly. Journal of the American Geriatric Society 31: 137–143, 1983

    CAS  Google Scholar 

  • Brody JA, Foley DJ. Epidemiologic considerations. In Schneider et al. (Eds) The teaching nursing home, pp. 9–25, Raven Press, New York, 1985

    Google Scholar 

  • Crooks J, O’Malley K, Stevenson IH. Pharmacokinetics in the elderly. Clinical Pharmacokinetics 1: 280–296, 1976

    Article  PubMed  CAS  Google Scholar 

  • Dawling S, Crome P. Clinical pharmacokinetic considerations in the elderly - an update. Clinical Pharmacokinetics 17: 236–263, 1989

    Article  PubMed  CAS  Google Scholar 

  • Divoll M, Abernethy DR, Ameer B, Greenblatt DJ. Acetaminophen kinetics in the elderly. Clinical Pharmacology and Therapeutics 31: 151–156, 1982

    Article  PubMed  CAS  Google Scholar 

  • Greenblatt DJ, Divoll M, Abernethy DR, Harmatz JS, Shader RI. Antipyrine kinetics in the elderly: prediction of age-related changes in benzodiazepine oxidizing capacity. Journal of Pharmacology and Experimental Therapeutics 220: 120–126, 1982a

    PubMed  CAS  Google Scholar 

  • Greenblatt DJ, Sellers EM, Shader RI. Drug disposition in old age. New England Journal of Medicine 306: 1081–1088, 1982b

    Article  PubMed  CAS  Google Scholar 

  • Hall DA (Ed). The biomedical basis of gerontology, pp. 1–8, Wright-PSG, Bristol, London and Boston 1984

    Google Scholar 

  • Homer TD, Stanski DR. The effect of increasing age on thiopental disposition and anesthetic requirement. Anesthesiology 62: 714–724, 1985

    Article  PubMed  CAS  Google Scholar 

  • Libow LS, Starer P. Care of the nursing home patient. New Zealand Journal of Medicine 321: 93–96, 1989

    CAS  Google Scholar 

  • Lindeman RD, Tobin J, Shock N. Longitudinal studies on rate of decline in renal function with age. Journal of the American Geriatric Society 33: 278–285, 1985

    CAS  Google Scholar 

  • Montamat SC, Cusack BJ, Vestal RE. Management of drug therapy in the elderly. New England Journal of Medicine 321: 303–309, 1989

    Article  PubMed  CAS  Google Scholar 

  • Ostfeld AM. Older research subjects: not homogeneous, not especially vulnerable IRB 2: 7–8, 1980

    Article  PubMed  Google Scholar 

  • Ratzan RM. The experiment that wasn’t: a case report in clinial geriatric research. Gerontology 21: 297–302, 1981

    Article  CAS  Google Scholar 

  • Reidenberg MM, Cancho MC, Kluger J, Drayer DE. Aging and renal clearance of procainamide and acetylprocainamide. Clinical Pharmacology and Therapeutics 28: 732–735, 1980

    Article  PubMed  CAS  Google Scholar 

  • Rodeheffer RJ, Gerstenblith F, Becker LC, Fleg JL, Weisfeldt ML, et al. Exercise cardiac output is maintained with advancing age in healthy human subjects: cardiac dilatation and increased stroke volume compensate for diminished heart rate. Circulation 69: 203–213, 1984

    Article  PubMed  CAS  Google Scholar 

  • Rowe JW. Clinical research on aging: strategies and directions. New England Journal of Medicine 297: 1332–1336,1977

    Article  PubMed  Google Scholar 

  • Sheiner LB, Rosenberg B, Marathe VV. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. Journal of Pharmacokinetics and Biopharmaceutics 5: 445–479, 1977

    Article  PubMed  CAS  Google Scholar 

  • Shock NW. Functional changes in aging. Program and Papers of Conference of Gerontology, pp. 123, Duke University, 1959

  • Svenson CK. Ethical considerations in the conduct of clinical pharmacokinelic studies. Clinical Pharmacokinetics 17: 217–222, 1989

    Article  Google Scholar 

  • Vestal RE, Norris AH, Tobin JD, Cohen BH, Shock NW, et al. Antipyrine metabolism in man: influence of age, alcohol, caffeine and smoking. Clinical Pharmacology and Therapeutics 18: 425–432, 1975

    PubMed  CAS  Google Scholar 

  • Williams TF. Aging or disease. Clinical Pharmacology and Therapeutics 42: 663–665, 1987

    Article  PubMed  CAS  Google Scholar 

  • Zimmer AW, Calkins E, Hadley E, Ostfeld AM, Kaye JM, et al. Conducting clinical research in geriatric populations. Annals of Internal Medicine 103: 276–283, 1985

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Brown University School of Medicine, Providence, Rhode Island, USA

    Darrell R. Abernethy &  Daniel L. Azarnoff

Authors
  1. Darrell R. Abernethy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel L. Azarnoff
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abernethy, D.R., Azarnoff, D.L. Pharmacokinetic Investigations in Elderly Patients Clinical and Ethical Considerations. Clin Pharmacokinet 19, 89–93 (1990). https://doi.org/10.2165/00003088-199019020-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-199019020-00001

Keywords

Search

Navigation